Articles On Althea Group Holdings (ASX:AGH)

ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were then hammered in the March downturn. Last year wasn’t much better, with the vaping crisis and slow roll out of Canada...

Pharmaceutical company Althea Group (ASX: AGH) has added Germany to its list of active markets following the signing of a 3-year supply and distribution agreement with German wholesaler Nimbus Health. Althea will now see its products sold i...

ASX cannabis shares have proven to be susceptible to coronavirus, with valuations slashed in the recent market downturn. This is the second crisis to hit cannabis shares in the past year, after the “vape crisis” in late 2019.  The current...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is storming higher on Tuesday. The benchmark index is currently up 2.5% to 5,419.9 points. Three healthcare shares that are vastly outperforming the benchmark i...

ASX cannabis shares have been hammered in the market downturn as investors turn to safe-haven assets. But while the market has been distracted by the fallout from the coronavirus pandemic, ASX cannabis shares have been quietly expanding th...

Pharmaceutical company Althea Group (ASX: AGH) has published an interim update regarding its active businesses in Australia, Canada and the UK, declaring that February bettered January as the company’s second-best month on record. The compa...

The Althea Group Holdings Ltd (ASX: AGH) share price has fallen materially over the last few weeks following the coronavirus-induced market volatility. In fact, it isn’t just Althea which has been impacted. The likes of Auscann Group Holdi...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and is zooming higher on Tuesday morning. At the time of writing the cannabis company’s shares are up 11% to 34.5 cents. Why was the THC Global share price...

Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c...

The Althea Group Holdings Ltd (ASX: AGH) share price is sinking lower today as the medicinal cannabis producer released its half-year results.  After opening relatively flat this morning, Althea shares are now down 7.69% to $0.30 apiece. A...

As cannabis regulation in the US inches forward, there are now 11 states where the drug is legal for both medical and recreational purposes. An important new player — New York — is expected to become the 12th state later this year. And in t...

The S&P/ASX 200 index is on course to record a strong gain on Tuesday. In afternoon trade the benchmark index is up 0.7% to 7,062.9 points. Four shares that are climbing more than most today are listed below. Here’s why they are surgin...

Pharmaceutical company Althea Group (AGH) has enjoyed strong patient growth throughout January The first month of 2020 became the second-best on record for the company, with 572 new patients added to Althea’s database Almost 5000 patients...

The Althea Group Holdings Ltd (ASX: AGH) share price has stormed higher in morning trade. At the time of writing the cannabis company’s shares are up 4% to 39 cents. Why is the Althea share price pushing higher? Investors have been buying...

The breakdown in the corporate North American marijuana sector is having ramifications in the Australian industry, and it’s unclear how big an impact the ructions will continue to have. Lower than expected take up of recreational marijuana...

Cann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse, saying a global oversupply has led it to change plans. Furthermore, major shareholder Aurora says it won’t participate in any new funding r...

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a strong performer on Thursday. In morning trade the cannabis company’s shares have jumped 12% higher to 3.7 cents. Why is the MGC Pharma share price jumping higher today? Hot on...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 1.39% t...

Medicinal cannabis company Althea (ASX: AGH) had a stellar finish to an eventful 2019 with more than 4,000 patients prescribed in Australia. Founded by Joshua Fegan (pictured), who won Trailblazer of the Year at the Melbourne Young Entrep...

Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical...

Althea Group Holdings Ltd (ASX: AGH) shares have jumped as much as 6% higher this morning after a strong operational update from the ASX cannabis company. At the time of writing, Althea shares are trading for 48 cents, up 3.26%. What did...

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

Last year was a bear market for cannabis stocks globally. During 2019, the excitement that had followed the legalisation of marijuana in many jurisdictions was replaced by cautio as investors realised early forecasts weren’t necessarily ma...

The Cann Group Ltd (ASX: CAN) share price has started the week on an incredibly positive note. At the time of writing the cannabis company’s shares are the best performers on the All Ordinaries index. In afternoon trade they are up a massi...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

An Initial Public Offering (IPO) is a process in which a private company offers its shares to the public through stock issuance. An IPO is the best way for a company to raise a substantial amount of capital to expand its operations. The fun...

The Elixinol Global Ltd (ASX: EXL) share price looks set to end the week on a very disappointing note. The cannabis company’s shares are down over 9% to a 52-week low of 58 cents this afternoon. This means Elixinol Global’s shares have fal...

Cannabis shares have had a bad run in the second half of 2019. Prices have retreated from the highs seen earlier in the year, led lower by North American cannabis stocks. Could 2020 see a reversal in fortunes? We take a look at 2 ASX cann...

The cannabis industry is one of the most debated sectors at a global scale, and significant progress has been seen in this industry worldwide. Medicinal cannabis products manufactured in Australia must be created under a Good Manufacturing...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.04% to ...

A newly granted growing license means ECS Botanics (ASX:ECS)  can start preparing a facility to grow medical cannabis in Tasmania. The company says the licence will allow it to grow cannabis once they have a permit, produce resin for medica...

The Althea Group Holdings Ltd (ASX: AGH) share price is charging higher in morning trade. At the time of writing the cannabis company’s shares are up 13% to 39 cents. Why is the Althea share price on a high? Investors have been buying Alth...

Emerging or early-stage companies offer new investment opportunities to investors, and higher returns are expected from start-ups due to their potential for growth. Investing in early-stage companies is risky; however, it offers the potenti...

Short & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorted. Stocks that are shorted have investors betting that they fall. Shorting works by selling stocks you do not actually own in the hope of bu...

Cannabis remains to be a subject of high speculation across the globe, even though significant advancement has been made in this field. A topic of taboo once, cannabis currently is one of the most discussed business opportunities globally,...

Cannabis shares have continued their bumpy ride in November. Marijuana shares globally are trading well down from previous highs, which has impacted our ASX marijuana shares.  The intoxication that greeted the sector earlier this year has...

The Althea Group Holdings Ltd (ASX: AGH) share price is recovering from its early fall today after an update from the company’s annual general meeting (AGM). What were Althea’s FY19 highlights? CEO Joshua Fegan noted the big steps taken by...

Thailand has not yet legalised marijuana but pretty soon Thais will not only be able to grow their own plants but they will be allowed to sell them to the government. “In the near future, families will be able to plant cannabis trees in the...

Lately, cannabis stocks in the US have come under pressure, following the rising death toll from vaping that reached 42 so far in 2019, according to media reports. Meanwhile, in Canada, Canopy Growth unveiled that returned cannabis oil prod...

The market may be trading lower today, but one group of shares is falling more than most – the cannabis companies. In early afternoon trade the cannabis industry is a sea of red as investors head for the exits in their droves. Here’s a sum...

Health care in Australia is the most diversified and dynamic sector and has the potential to generate significant revenues for the Australian economy. The health care sector comprises of companies engaged in drug development and R&D act...

15 Nov 2019 - Medicinal cannabis company Althea Group Holdings (ASX:AGH) has seen an uptake of its medicinal cannabis products in Australia.

Althea Group (ASX: AGH) continues to make inroads into the European market with operations in both the UK and Germany now online, supported by its proprietary technology platform Althea Concierge. The medicinal cannabis company is also maki...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to end the week on a high. The cannabis company’s shares are up over 4% to 49 cents on Friday morning. Why is the Althea share price racing higher? Investors have responded...

In this article we are discussing five ASX-listed health care stocks, Althea Group Holdings Limited (ASX: AGH), Botanix Pharmaceuticals Limited (ASX:BOT), SDI Limited (ASX: SDI), Mach7 Technologies Limited (ASX: M7T), OncoSil Medical Limite...

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has raced higher following the release of an update. At the time of writing the cannabis company’s shares are up 7% to 51 cents. Why is the Althea share price on a high...

Cannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after the legalization of cannabis for medicinal as well as recreational purposes. The cannabis industry refers to the activities and all the profe...

At time of writing, the share price of Althea Group Holdings Ltd [ASX:AGH] is up 2.3%, trading at 44.5 cents. The Althea share price appears to have found support around a price that dates back to April. We examine the details of their late...

Orthocell (ASX:OCC) has found a new use for its CelGro tech – anterior cruciate ligament (ACL) injuries. The ACL is a major stabilising ligament in the knee. Once it is ruptured, it cannot be healed it must be replaced and recovery takes se...